Search results
Cerity Partners LLC Acquires New Position in Teva Pharmaceutical Industries Limited (NYSE:TEVA)
ETF DAILY NEWS· 1 day agoCerity Partners LLC purchased a new stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) during the 4th quarter, according ...
Teva's Revive Collections Travels Back to the 2000s, Photos
Footwear News via Yahoo News· 1 day agoCelebrating its 40th anniversary and giving continuity to its Revive Collections, Teva has launched...
Earnings call: Corcept Therapeutics raises 2024 revenue guidance By Investing.com
Investing.com· 3 hours agoThe company has also raised its revenue guidance for the full year to between $620 million and $650...
Q1 2024 Corcept Therapeutics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 49 minutes agoI will now turn the call over to Charlie Robb, our Chief Business Officer. Charlie? Gary Robb Thanks, Atabak. In March 2018, we sued Teva Pharmaceuticals to prevent it from ...
Spring Has Sprung Obviousness Trends from the Federal Circuit
The National Law Review· 18 hours agoAt the beginning of the month, in Janssen Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc....
US FDA approves Neurocrine Biosciences' movement disorder drug (April 30)
Reuters· 2 hours ago, opens new tab Ingrezza drug to treat movement disorders associated with Huntington's disease (HD), the company said on Tuesday. Huntington's disease is an inherited condition that causes the ...
Generic Drug Giant Teva Hires New Legal Chief After DOJ Deal
Bloomberg Law· 2 days agoTeva Pharmaceutical Industries Ltd. has a new chief legal officer in David McAvoy, who succeeds David Stark as the top lawyer for the world’s largest generic drug manufacturer.
Corcept Therapeutics Inc (CORT) Q1 2024 Earnings Call Transcript Highlights: Strong Growth Amid ...
GuruFocus.com via Yahoo Finance· 5 hours agoNegative Points Corcept Therapeutics Inc faces significant legal challenges, including a recent court ruling allowing Teva Pharmaceuticals to market a generic version of Korlym ...
FTC targets ‘junk patents’ on Ozempic, other top drugs
BioPharma Dive via Yahoo Finance· 1 day agoThe move broadens the antitrust regulator’s campaign against allegedly “improper or inaccurate”...
21 best sandals for walking all day long, according to podiatrists
CNN via Yahoo News· 2 days ago“It still looks nice but provides a bit more comfort for more active outings. I wear mostly whites,...
